Supernus Pharma (SUPN)
43.53
-0.44 (1.00%)
Upcoming Events
Latest Headlines
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 2, 2026 4:30 PM - StreetInsider
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Khattar Jack A.
August 14, 2026 5:13 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Rubin Jonathan
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Mottola Frank
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Bhatt Padmanabh P.
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: DEC TIMOTHY C
August 14, 2026 5:10 PM - SEC Filing
Form SCHEDULE 13G/A SUPERNUS PHARMACEUTICALS Filed by: MILLENNIUM MANAGEMENT LLC
August 6, 2026 6:49 PM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: Indivior Pharmaceuticals, Inc.
August 4, 2026 6:02 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: Indivior Pharmaceuticals, Inc.
August 3, 2026 5:25 PM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 5:06 PM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 5:04 PM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 5:01 PM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 8:37 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 8:36 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 8:34 AM - SEC Filing
Supernus jumps premarket on merger deal; GameStop drops
August 3, 2026 8:04 AM - StreetInsider
Supernus Pharma (SUPN) Misses Q2 EPS by 144c
August 3, 2026 7:09 AM - StreetInsider
Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30
August 3, 2026 6:56 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 6:47 AM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 6:47 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 6:46 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 01
August 3, 2026 6:44 AM - SEC Filing
Supernus Announces Second Quarter 2026 Financial Results
August 3, 2026 6:35 AM - StreetInsider
Supernus and Indivior agree to all-stock merger of equals
August 3, 2026 6:31 AM - StreetInsider
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026 6:30 AM - StreetInsider
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Khattar Jack A.
July 31, 2026 5:07 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: DEC TIMOTHY C
July 31, 2026 5:06 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Mottola Frank
July 31, 2026 5:05 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Bhatt Padmanabh P.
July 31, 2026 5:05 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Rubin Jonathan
July 31, 2026 5:04 PM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 22
July 22, 2026 5:07 PM - SEC Filing
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
July 22, 2026 5:05 PM - Globe NewsWire
Supernus Pharma (SUPN) call put ratio 1 call to 4 puts
July 16, 2026 6:14 AM - StreetInsider
Supernus marks five years of Qelbree ADHD drug with 3M prescriptions
July 14, 2026 8:30 AM - StreetInsider
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
July 14, 2026 8:30 AM - StreetInsider
Form S-8 SUPERNUS PHARMACEUTICALS
June 22, 2026 4:46 PM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 18
June 18, 2026 4:56 PM - SEC Filing
Supernus names MERGE as agency of record for its CNS portfolio
June 17, 2026 10:15 AM - StreetInsider
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
June 17, 2026 10:15 AM - StreetInsider
Full Article List
